Shockwave Medical (Nasdaq:SWAV) - Aandelenkoers, Nieuws & Analyse

SWAV Overzicht aandelen

A medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. Meer informatie

SWAV fundamentele analyse
Sneeuwvlok Score
Waardering	1/6
Toekomstige groei	3/6
Prestaties in het verleden	3/6
Financiële gezondheid	5/6
Dividenden	0/6

Beloningen

De winst zal naar verwachting met 18.35% per jaar groeien

Risicoanalyse

Aandeelhouders zijn het afgelopen jaar verwaterd

Winstmarges (20.7%) zijn lager dan vorig jaar (43.2%)

Shockwave Medical, Inc. Concurrenten

Globus Medical

NYSE:GMED

US$11.6b

Insulet

NasdaqGS:PODD

US$18.4b

Inspire Medical Systems

NYSE:INSP

US$5.6b

Masimo

NasdaqGS:MASI

US$9.1b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Shockwave Medical
Historische aandelenkoersen
Huidige aandelenkoers	US$334.75
52 Week Hoogtepunt	US$334.90
52 Week Laag	US$157.00
Bèta	0.88
11 maand verandering	1.49%
3 maanden verandering	27.08%
1 Jaar Verandering	15.77%
33 jaar verandering	97.43%
5 jaar verandering	432.11%
Verandering sinds IPO	997.54%

Recent nieuws en updates

Recent updates

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Apr 06

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Mar 24

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 18

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Feb 06

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jan 24

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Jan 09

Rendement voor aandeelhouders

	SWAV	US Medical Equipment	US Markt
7D	0.2%	1.5%	2.2%
1Y	15.8%	20.9%	31.7%

Rendement versus industrie: SWAV overtrof de US Medical Equipment industrie, die het afgelopen jaar een rendement 20.9 % opleverde.

Rendement versus markt: SWAV presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 31.7 % opleverde.

Prijsvolatiliteit

Is SWAV's price volatile compared to industry and market?
SWAV volatility
SWAV Average Weekly Movement	3.6%
Medical Equipment Industry Average Movement	8.1%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.8%
10% least volatile stocks in US Market	3.1%

Stabiele aandelenkoers: SWAV heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van SWAV is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2009	1,468	Doug Godshall	shockwavemedical.com

Shockwave Medical, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Shockwave Medical zich tot de beurswaarde?
SWAV fundamentele statistieken
Marktkapitalisatie	US$12.57b
Inkomsten(TTM)	US$163.50m
Inkomsten(TTM)	US$787.97m

76.9x

Koers/Winstverhouding

15.9x

P/S-verhouding

Is SWAV overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
SWAV resultatenrekening (TTM)
Inkomsten	US$787.97m
Kosten van inkomsten	US$102.53m
Brutowinst	US$685.44m
Overige uitgaven	US$521.94m
Inkomsten	US$163.50m

Laatst gerapporteerde inkomsten

Mar 31, 2024

Volgende inkomensdatum

Aug 05, 2024

Winst per aandeel (EPS)	4.35
Brutomarge	86.99%
Nettowinstmarge	20.75%
Schuld/Eigen Vermogen Verhouding	97.5%

Hoe presteerde SWAV op de lange termijn?

Bekijk historische prestaties en vergelijking

SWAV Overzicht aandelen

Beloningen

Risicoanalyse

Shockwave Medical, Inc. Concurrenten

NYSE:GMED

US$11.6b

NasdaqGS:PODD

US$18.4b

NYSE:INSP

US$5.6b

NasdaqGS:MASI

US$9.1b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024

Shockwave Medical, Inc. Announces U.S. Launch of the Shockwave E8 Peripheral Ivl Catheter

Shockwave Medical Files Form 15

Shockwave's Common Stock Ceases Trading on NASDAQ

Shockwave Medical, Inc. Announces Termination of Employment of Renee Gaeta as Chief Financial Officer

Johnson & Johnson (NYSE:JNJ) completed the acquisition of Shockwave Medical, Inc. (NasdaqGS:SWAV) from a group of sellers.

Recent updates

Shockwave Medical Unveils First Clinical Outcomes of New IVL Platform in Late-Breaking Presentation at VIVA 2024

Shockwave Medical, Inc. Announces U.S. Launch of the Shockwave E8 Peripheral Ivl Catheter

Shockwave Medical Files Form 15

Shockwave's Common Stock Ceases Trading on NASDAQ

Shockwave Medical, Inc. Announces Termination of Employment of Renee Gaeta as Chief Financial Officer

Johnson & Johnson (NYSE:JNJ) completed the acquisition of Shockwave Medical, Inc. (NasdaqGS:SWAV) from a group of sellers.

Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Shockwave Medical, Inc., Annual General Meeting, May 29, 2024

Price target increased by 7.7% to US$302

Shockwave Medical, Inc. Announces Investigators Presented Six-Month Data from the Full Population of the Reducer-I Study

Johnson & Johnson (NYSE:JNJ) entered into a definitive agreement to acquire Shockwave Medical, Inc. (NasdaqGS:SWAV) for $13 billion.

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Johnson & Johnson (NYSE:JNJ) entered into a definitive agreement to acquire Shockwave Medical, Inc. (NasdaqGS:SWAV) for $13 billion.

Price target increased by 9.7% to US$286

Insufficient new directors

Johnson & Johnson Reportedly Considers Deal for Shockwave Medical

Chief Commercial Officer notifies of intention to sell stock

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Independent Director notifies of intention to sell stock

Chief Commercial Officer notifies of intention to sell stock

Shockwave Medical: Opening Arteries, Delivering Returns

New minor risk - Shareholder dilution

Independent Director recently sold US$15m worth of stock

Now 21% undervalued

Consensus EPS estimates increase by 12%

President exercised options and sold US$2.3m worth of stock

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Full year 2023 earnings: EPS exceeds analyst expectations

Shockwave Medical, Inc. Provides Earnings Guidance for 2024

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Shockwave Medical, Inc. Appoints Renee Gaeta as Chief Financial Officer, Effective February 5, 2024

Chief Commercial Officer notifies of intention to sell stock

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

President notifies of intention to sell stock

Shockwave Medical, Inc. to Report Q4, 2023 Results on Feb 15, 2024

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

President notifies of intention to sell stock

Is Shockwave Medical (NASDAQ:SWAV) A Risky Investment?

Chief Commercial Officer notifies of intention to sell stock

President exercised options and sold US$922k worth of stock

Do Shockwave Medical's (NASDAQ:SWAV) Earnings Warrant Your Attention?

Now 21% undervalued after recent price drop

President notifies of intention to sell stock

What Is Shockwave Medical, Inc.'s (NASDAQ:SWAV) Share Price Doing?

Investor sentiment deteriorates as stock falls 25%

Shockwave Medical, Inc. Announces New Data Demonstrating One-Year Outcomes with Coronary Lithotripsy

Now 22% undervalued after recent price drop

Shockwave Medical, Inc. Provides Revenue Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Price target decreased by 13% to US$241

Shockwave Medical, Inc. Introduces Enhanced Coronary IVL Catheter in the United States

Shockwave Medical, Inc. Announces New Shockwave Coronary IVL Publications Confirm Safety and Efficacy Across Multiple Calcium Morphologies

Is Shockwave Medical, Inc. (NASDAQ:SWAV) Trading At A 50% Discount?

President notifies of intention to sell stock

Shockwave Medical (NASDAQ:SWAV) Is Very Good At Capital Allocation

Shockwave Medical (NASDAQ:SWAV) Has A Rock Solid Balance Sheet

President notifies of intention to sell stock

Shockwave Medical, Inc. Appoints Nick West as Associate Chief Medical Officer